< Back to latest news & events

Blogs

Innovating the Future of Healthcare: Patent Filing Trends in Europe

March 2023

The healthcare industry has experienced a significant transformation over the past few years, and this looks to be only the start of a significant re-think of how healthcare is provided, driven by new technologies and digital health innovation.

Digital technology has revolutionized the way healthcare is delivered, from remote patient monitoring and virtual consultations, through AI analysis of medical data and images, personalised healthcare and more, with aims of making healthcare more accessible, efficient, and cost-effective, and reducing the burden on healthcare providers such as the NHS in the UK.

Recent patent filing statistics from the European Patent Office (EPO) demonstrate the extent of the boom in digital health innovation, with a significant increase in the number of patent filings related to digital health.

The number of European patent applications in the field of digital communication has been steadily increasing over the past several years, with a worldwide 11.2% increase in the past year alone, making it the number one filing area. Similarly, medical technology filings have remained in the number two spot for the number of filings with a 1% increase in 2022, with computer technology a close third for number of filings and with a 1.8% increase in filing numbers in 2022.

 

So, what is driving this growth in digital health innovation? One factor may be the increasing demand for healthcare services, which is putting pressure on healthcare systems to find more efficient ways to deliver care. Digital health technologies, such as telemedicine, remote patient monitoring, and mobile health apps, can help to address this demand by allowing patients to access care from anywhere at any time, and by facilitating more preventive treatments, powered in part by advances in artificial intelligence (AI) and the Internet of Things (IoT) innovation.

AI and IoT are currently undergoing rapid development to provide new, implementable, computing and communications technologies. AI and IoT innovations are being integrated into healthcare systems and aim to facilitate improved diagnosis, indication of potential preventative action to mitigate against future healthcare issues, and improve patient outcomes. For example, AI-powered algorithms can help doctors to diagnose diseases more accurately and quickly, while IoT devices can provide real-time data on patient health and activity and alert healthcare providers to potential issues in various healthcare environments.

Looking at the filing trends in digital health by country, there are also some interesting patterns. Europe has seen an steady increase in filing numbers in the field of medical technology as well as the USA, China and Korea. Focussing on Europe, medical technology filings have increased in recent years most notably in Switzerland, the UK, and Ireland.

In 2022, the UK saw the highest number of applications being filed in the fields of computing (8.9%) and medical technology (8.7%). Medical technology accounts for around a quarter (24.8%) of all patent applications from Ireland, with 12.4% of filings relating to computer technology and 10.2% to pharmaceuticals.

 

It will be interesting to see how these trends pan out as emerging digital health technologies start to mature, in particular in the UK and Ireland based on the current trends in European patent filing data, so watch this space!

If you have any questions about patenting in the digital health space, please feel free to get in touch with us and we will find the right person for you to speak to. HGF have a diverse team of attorneys based across Europe, with experts in MedTech and digital health technologies based in the UK and Ireland.


This article was prepared by HGF Patent Director Dr Janine Swarbrick.

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

WIPR Diversity Top 100 2025

HGF’s European Patent Attorney Alexandra Wood has been listed in World IP Review’s (WIPR) Diversity Top 100 2025 World IP Review’s Diversity in IP listings 2025 recognises and celebrates people …

Read article

INTA 2025 Annual Meeting Live

The HGF European team will be attending the INTA Annual Meeting Live, which will take place on 17th-21st May in San Diego, US. The conference will connect some of the …

Read article

HGF wins big at the Managing IP EMEA Awards Ceremony 2025

The Annual Managing IP Awards: EMEA Awards 2025 were announced last night, and HGF are proud to have won 7 awards. The Managing IP Awards are highly recognised and respected …

Read article

Plant Patent Infringement in the US Relies on Evidence of Asexual Reproduction

A recent case in the US District Court for the Northern District of Texas (Dallas Division) once again highlights how important the initial pleadings and evidence in patent infringement cases …

Read article

Exam Success at HGF!

HGF is pleased to announce that several of our attorneys have passed their UK Advanced Patent exams! In no specific order, we would like to say well done and a …

Read article

IP Ingredients: How food companies are using IP to stay ahead of the GLP-1 curve

The impact of GLP-1 on the food and beverage sector GLP-1 agonists, best-known under the brand names Ozempic® and Wegovy®, are medicines used to treat type 2 diabetes and obesity. …

Read article